Purchase Order 75F40120P00210
- Not listed
- The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price purchase order to Molecular Devices LLC, a subsidiary of Danaher Corporation, for the supply of an AUTOMATIC COLONY PICKER QPIX 420. The contract, which has a potential value of $182,748.00, was awarded on June 26, 2018, with a completion date of September 25, 2021. The contract does not appear to have a set-aside designation. As a provider of high-performance bioanalytical measurement...
- This is a $350,000.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Molecular Devices LLC, a subsidiary of Danaher Corporation, for the provision of CLONEPIX II laboratory equipment. The contract has an ultimate completion date of October 30, 2015 and was awarded on September 10, 2015. No set-aside designation was used for this award. Molecular Devices LLC is a leading provider of bioanalytical measurement solutions for life science...
- The Food and Drug Administration awarded a $41,309.15 firm fixed price purchase order to Molecular Devices LLC for preventative maintenance and unlimited repair services on a Molecular Devices ImageXpress Micro Confocal High Content Imaging System. The contract, awarded July 1, 2024, with an ultimate completion date of June 30, 2025, was issued without a set-aside designation. Services will be performed at the National Center for Toxicological Research facility in Jefferson, Arkansas, and...
- Molecular Devices LLC, a San Jose-based subsidiary of Danaher Corporation specializing in advanced bioanalytical measurement solutions, was awarded a $17,732.05 firm fixed-price purchase order for microchip scanner service by a civilian agency within the Southeast Area. The contract, awarded on March 6, 2015, with an ultimate completion date of June 6, 2015, is to be performed in Sunnyvale, California. No set-aside designation was applied to this award, reflecting the contractor's competitive...
- <p>The Food and Drug Administration awarded a purchase order to Molecular Devices LLC for $189,000 on August 16, 2022, for a confocal upgrade. Work is performed in San Jose, California. The order is firm fixed price with an ultimate completion date of August 15, 2023.</p>
- The National Institutes of Health, through its Office of Logistics and Acquisition Operations, awarded a purchase order to Molecular Devices LLC valued at $29,119.20 on May 13, 2020, for firm fixed price procurement of bioanalytical measurement solutions and related scientific equipment. No set-aside was used. Work is performed at Molecular Devices' facility in San Jose, California, with ultimate completion scheduled for May 15, 2020. Molecular Devices is a subsidiary of Danaher Corporation...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract, valued at $24,946.00, is for a "Service Plan on a Fluorescent Imaging Plate Reader." The contract has no set-aside designation. Molecular Devices LLC is a for-profit limited liability company that specializes in providing high-performance bioanalytical measurement solutions, including sophisticated laboratory...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $287,976.64 firm fixed price purchase order to Molecular Devices, LLC for a BLI Detection System. As a prime contractor, Molecular Devices will deliver the requested detection system to support HHS FDA programs. Performance will occur at Molecular Devices' San Jose, California location from March 2020 through August 2020. No set aside designation or subcontractors were indicated. The award provides the...
- The Food and Drug Administration awarded a $22.9K firm fixed price purchase order to Molecular Devices LLC for preventative maintenance and repair services on a SpectraMax M2E microplate cuvette reader (Serial #DE05277) located in Silver Spring, Maryland. The contract, awarded on July 22, 2019, with a completion date of July 21, 2021, carries no set-aside designation, reflecting competitive procurement practices. Molecular Devices LLC, a San Jose, California-based subsidiary of Danaher...
- Molecular Devices LLC, a San Jose-based subsidiary of Danaher Corporation, has been awarded a $196,388.66 firm fixed-price purchase order by the Defense Health Agency for preventative maintenance and onsite performance assurance services supporting scientific equipment used in warfighter applications. The contract, issued January 1, 2024, extends through December 31, 2028, and will be performed at the agency's facility in Silver Spring, Maryland. This award reflects Molecular Devices'...
The Food and Drug Administration awarded a $1.02M firm fixed-price purchase order to Molecular Devices LLC on July 23, 2020, for robotic arm replacement on CLONEPIX2 equipment. The contract, which carries no set-aside designation, was performed in Silver Spring, Maryland, with an ultimate completion date of September 2, 2024. Molecular Devices LLC, a San Jose-based subsidiary of Danaher Corporation, is a leading manufacturer of advanced bioanalytical measurement solutions and specialized laboratory instruments serving federal agencies across the life sciences and pharmaceutical research sectors. The scope of work involves replacement components for the CLONEPIX2 system, a high-content imaging platform used in pharmaceutical development and biotherapeutic research. Molecular Devices maintains a robust federal contracting presence, particularly with the National Institutes of Health, CDC, and FDA, providing equipment, maintenance agreements, and repair services. As the original equipment manufacturer with proprietary technologies, the company typically receives non-competitive awards reflecting its specialized market position and critical role in supporting federal research infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Other Administrative Action | $0 | 3/14/24 | |
| P00004 | Other Administrative Action | $0 | 2/24/23 | |
| P00003 | Other Administrative Action | $0 | 8/21/22 | |
| P00002 | Exercise an Option | $36.3k | 3/5/22 | |
| P00001 | Exercise an Option | $36.3k | 1/19/21 |